ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N05AH04 | G | Quetiapine - 25mg | 8242 | 63814/1 | QUETIAPINE/ GENEPHARM | 25mg | 60 | Tablet, film coated | Oral | Nobel Pharm Plus SARL | Genepharm SA | Greece | 632,837 L.L | 23.08 | A2 | Genepharm SA | Greece | 2/1/2023 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N05AH04 | G | Quetiapine - 25mg | 8382 | 104314/1 | JOSWE QUZAL 25 | 25mg | 30 | Tablet | Oral | Eva Pharm Plus | Joswe Medical (Jordan Sweden Medical and Sterilization Co) | Jordan | 468,243 L.L | 23.08 | A1 | Joswe Medical (Jordan Sweden Medical and Sterilization Co) | Jordan | 2/1/2023 |
N05AH04 | G | Quetiapine - 25mg | 8383 | 104414/1 | JOSWE QUZAL 25 | 25mg | 60 | Tablet | Oral | Eva Pharm Plus | Joswe Medical (Jordan Sweden Medical and Sterilization Co) | Jordan | 937,431 L.L | 23.08 | A2 | Joswe Medical (Jordan Sweden Medical and Sterilization Co) | Jordan | 2/1/2023 |
N05AH04 | G | Quetiapine fumarate - 25mg | 8515 | 96815/1 | PMS-QUETIAPINE | 25mg | 100 | Tablet | Oral | UPO S.A.L. | Pharmascience Inc | Canada | 573,243 L.L | 23.08 | A2 | Pharmascience Inc | Canada | 2/1/2023 |
N05AH04 | G | Quetiapine fumarate - 25mg | 10702 | 221908/08 | SEROPINE 25 | 25mg | 60 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 575,192 L.L | 23.08 | B | 2/1/2023 | ||
N05AH04 | B | Quetiapine fumarate - 25mg | 1580 | 405475/00 | SEROQUEL | 25mg | 60 | Tablet, film coated | Oral | Omnipharma | AstraZeneca UK Ltd | UK | 316,557 L.L | 23.08 | B | AstraZeneca UK Ltd | UK | 2/1/2023 |